Tekla Life Sciences Investors (HQL) Insider Trading

Total insider buys:
  • $7,085,451.16
Total insider sells:
  • $6,607,374.39
Most recent insider trade:
  • Sept. 22, 2025
Most active insider trader:
  • Saba Capital Management, L.P.
Trader NameDateTitleAmountPriceTypeTotal Value
April 9, 2024Director400$13.32Buy$5,328.00
Jan. 2, 2024Director1,000$13.80Buy$13,800.00
Sept. 25, 2023President10,096$12.39Buy$125,089.44
Sept. 20, 2023President12,000$12.68Buy$152,160.00
March 23, 2022Director92$16.27Buy$1,496.84
Jan. 26, 2022Director593$17.54Buy$10,401.22
Aug. 11, 2021President6,403$21.63Buy$138,496.89
Oct. 26, 2020President6,175$17.52Buy$108,186.00
Oct. 21, 2020President5,950$17.75Buy$105,612.50
May 21, 2020President5,950$17.74Buy$105,553.00
March 17, 2020President8,300$13.27Buy$110,141.00
Jan. 25, 2018Director1,300$21.04Buy$27,352.00
First«2 of 2»Last
  • Insiders are both buying and selling Tekla Life Sciences Investors stock.

  • The insider traders at Tekla Life Sciences Investors are: Saba Capital Management, L.P., Daniel R Omstead, Kathleen Goetz, Thomas M Kent, Bill Maher, Todd Reit, Daniel R. Omstead, and Rose Dimartino

  • The most active insider trader at Tekla Life Sciences Investors is Saba Capital Management, L.P. with 48 trades.

  • Saba Capital Management, L.P. has sold the most Tekla Life Sciences Investors stock with a total value of $7,195,923.61.

  • Saba Capital Management, L.P. has bought the most Tekla Life Sciences Investors stock with a total value of $6,157,720.77.

  • The most recent insider trade for Tekla Life Sciences Investors was on Sept. 22, 2025.

  • The single biggest insider buy for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $1,563,952.00 on April 26, 2024.

  • The single biggest insider sell for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $611,677.34 on March 31, 2025.